<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000367459">
  <TermName>Triapine</TermName>
  <TermPronunciation>(TRY-uh-peen)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance being studied in the treatment of cancer. It is a type of ribonucleotide reductase inhibitor. Also called 3-aminopyridine-2-carboxaldehyde thiosemicarbazone and 3-AP.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000731293" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Triapine&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000731292" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Triapine&quot;" language="es" id="_4"/>
  <SpanishTermName>Triapine</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Es un tipo de inhibidor del ribonucleótido reductasa. También se llama 3-aminopiridina-2-carboxaldehído tiosemicarbazona y 3-AP.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2004-04-23</DateFirstPublished>
  <DateLastModified>2007-01-17</DateLastModified>
</GlossaryTerm>
